(Q39841354)

15 September 2017

title

Placenta growth factor is a survival factor for human malignant mesothelioma cells (English)

1 reference

15 September 2017

L Albonici

1

1 reference

15 September 2017

E Doldo

2

1 reference

15 September 2017

C Palumbo

3

1 reference

15 September 2017

A Orlandi

4

1 reference

15 September 2017

R Bei

5

1 reference

15 September 2017

E Pompeo

6

1 reference

15 September 2017

T C Mineo

7

1 reference

15 September 2017

A Modesti

8

1 reference

15 September 2017

V Manzari

9

1 reference

15 September 2017

publication date

1 April 2009

1 reference

International Journal of Immunopathology and Pharmacology

15 September 2017

published in

1 reference

15 September 2017

volume

22

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

389-401

1 reference

Advances in malignant mesothelioma

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Update on the molecular biology of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Vascular endothelial growth factor (VEGF) signaling in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

The biology of vascular endothelial growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Structure and function of placental growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Loss of placental growth factor protects mice against vascular permeability in pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Placenta growth factor expression is correlated with survival of patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Placenta growth factor is over-expressed and has prognostic value in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Establishment of human malignant mesothelioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Neuropilins in neoplasms: expression, regulation, and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Flt-1 signaling in macrophages promotes glioma growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Placental growth factor induces FosB and c-Fos gene expression via Flt-1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Persistent induction of c-fos and c-jun expression by asbestos

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

Immunity to extracellular matrix antigens is associated with ultrastructural alterations of the stroma and stratified epithelium basement membrane in the skin of Hashimotos thyroiditis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200216

10.1177/039463200902200216

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference